Grants

The international panel of expert reviewers are volunteers who are internationally-recognised experts in their field of expertise, they help to assess the relative merits of the many worthy applications for UICC Fellowships.

Over 500 international experts contribute more than 3000 hours of voluntary time to review applications each year.

UICC expresses its grateful appreciation to all of the reviewers, who reviewed over 150 applications in 2010. Their names are listed here.

Without the expertise and know-how of these voluntary expert reviewers, UICC would not be able to have such a wide-reaching effect on global cancer control. The collaboration of these volunteer expert reviewers is what enables our fellowships to function.

This international review panel works in conjunction with UICC Fellowships Project Chairs and ACSBI selection committee profiled below.

Dr Joe Harford
PhD Director

National Cancer Institute - USA - Bethesda

Dr. Joe Harford has a Ph.D. in Biochemistry and has conducted basic research in cell biology with in over 120 scientific publications.  In 1996, Dr. Harford was named Associate Director of the National Cancer Institute and Chief of Staff of the Office of the Director.  In 2002, Dr. Joe Harford became Director of the Office of International Affairs of the NCI where he has responsibility for interactions between the NCI and international entities.  Dr. Harford serves as the Chair of the Strategic Advisory Group of the Ireland-Northern Ireland-NCI Cancer Consortium and as NCI liaison to the Middle East Cancer Consortium (MECC), the US-Japan Cooperative Cancer Research Program, the African Organization for Research and Training in Cancer (AORTIC), the American-Russian Cancer Alliance (ARCA), and the International Network for Cancer Treatment and Research (INCTR). Dr. Harford is a member of the UICC American Cancer Society international fellowships for beginning investigators (ACSBI) Grants Committee.

 

Prof W. Nicol Keith, PhD
Group Leader, Telomerase Therapeutics

Nicol W. Keith is Professor of Molecular Oncology at the Institute of Cancer Sciences, Glasgow University in the UK.  Dr Keith’s research is focused on the development of novel therapeutics that target cellular senescence and telomerase. Dr Keith is a member of several national and international scientific committees and is particularly active within the Union for International Cancer Control (UICC) and Chairs both the UICC International Cancer Technology Transfer Fellowships (ICRETT) & Yamagiwa-Yoshida Memorial International study grants committees.  He is also a member of the UICC American Cancer Society international fellowships for beginning investigators (ACSBI) Grants Committee.

 

 

Dr Rob Jones MA, MBChB, PhD, FRCP 
Senior Lecturer in Clinical Pharmacology, Honorary Consultant Medical Oncologist
Cancer Research UK - Beatson Laboratories

Dr Rob Jones is a senior lecturer in medical oncology at the University of Glasgow. His interests include the design and execution of clinical trials, particularly those using new anti-cancer drugs. He also has an interest in the clinical aspects of new drug discovery and collaborates with basic science colleagues at the Beatson Institute for Cancer Research. His clinical practice is based at the Beatson West of Scotland Cancer Centre and focuses on the management of cancers of the prostate, bladder and kidney.

Dr Jones serves on the Union for International Cancer Control (UICC) as Co-Chair of the International cancer technology transfer fellowships (ICRETT) and member of the UICC American Cancer Society international fellowships for beginning investigators (ACSBI) Grants Committee.

 

David P. Ringer, PhD, 

MPH National Vice President
Extramural Grants Department
American Cancer Society  

Dr. Ringer received a PhD in Chemistry, with specialization in Biochemistry, from Wayne State University, and then a Masters of Public Health, specializing in Epidemiology and Biostatistics, from the University of Oklahoma.  Dr. Ringer joined the American Cancer Society as a Scientific Program Director the Extramural Grants (EG) Department in 1998.  In 2007, he was appointed Managing Director of Operations for the Department, the Vice President for the EG Department in 2009, and subsequently the National Vice President Extramural Research in 2010.  In addition, Dr. Ringer serves as the American Cancer Society staff member on the Union for International Cancer Control (UICC) ACSBI  committee for the selection of international cancer research fellowships for beginning investigators.

 

Zdenko Herceg, Ph.D.
Head of Epigenetics Group
International Agency for Research on Cancer (IARC), France

Dr Herceg joined IARC in 1997 and his laboratory conducts both mechanistic studies and epigenetic profiling, aiming to gain a better mechanistic understanding of tumorigenesis, and to discover and validate new epigenetic biomarkers. This programme exploits new concepts in cancer epigenetics and recent technological advances in epigenetics and epigenomics, and is carried out in close collaboration with national and international groups. Prior to joining IARC, he was a post-doctoral scientist at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria. He earned his Ph.D. from the University of St Andrews (UK) in the field of oncogenic transformation of human epithelial cells. He has authored a number of publications in the field of epigenetics, mechanisms of carcinogenesis, and cancer research.

Dr Herceg serves on the Union for International Cancer Control (UICC) ACSBI committee for the selection of international cancer research fellowships for beginning investigators.

 

Dr Robert A. Hiatt, M.D., Ph.D. 
Professor and Chair of the Department of Epidemiology and Biostatistics at UCSF and the Director of Population Science and Deputy Director of the UCSF Comprehensive Cancer Center.

From 1998 to early 2003 Dr Robert A. Hiatt was the first Deputy Director of the Division of Cancer Control and Population Sciences at the National Cancer Institute. He is a past president of the American College of Epidemiology and the American Society for Preventive Oncology. His research interests include cancer epidemiology, especially breast cancer, cancer prevention and screening, health services and outcomes research, the social determinants of cancer and breast cancer and early development. His central focus at UCSF is building a strong transdisciplinary research and training program in epidemiology with a focus on cancer population sciences. Dr. Hiatt serves on the Union for International Cancer Control (UICC) ACSBI committee for the selection of international cancer research fellowships for beginning investigators.

 

Prof. Evgeny N. Imyanitov 

Head of the Department of Tumor Growth Biology
N.N. Petrov Institute of Oncology
Head of the Department of Medical Genetics
St.-Petersburg Pediatric Medical Academy
Professor of Department of Oncology
Medical Academy for Postgraduate Studies, St.-Petersburg, Russia.

Prof. Imyanitov graduated from the I.P. Pavlov Medical School (St.-Petersburg, Russia) in 1989. Evgeny Imyanitov completed his PhD studies in N.N. Petrov Institute of Oncology (St.-Petersburg, Russia) in 1992, and received the IARC Fellowship for post-doctoral training in the Max Planck Institute of Biochemistry (Munich, Germany). In 1996 he returned to the home institute and established a research group. His current activities are focused on translational aspects of cancer science. In particular, the team of Prof. Imyanitov made a substantial contribution in the studies of hereditary cancer syndromes. In addition to clinically oriented research, the Evgeny Imyanitov’s laboratory investigates some basic aspects of cancer pathogenesis (systematic investigations on molecular features of bilateral breast cancer).  Prof. Imyanitov is an author of over 80 publications in internationally recognized scientific journals.

Prof Imyanitov is a member of the UICC American Cancer Society international fellowships for beginning investigators (ACSBI) Grants Committee.